Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism: AYKAN Trial

NCT02029456 is registered in ClinicalTrials.gov with Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital as lead sponsor.

NCT NCT02029456
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02029456 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low Dose Prolonged Infusion of Tissue Type Plasminogen Activator Therapy in Massive Pulmonary Embolism: AYKAN Trial
Lead sponsor
Ahi Evren Chest and Cardiovascular Surgery Education and Research Hospital
Phase
Phase 4
Overall status
Unknown status
Start date
June 30, 2011
Completion date
August 31, 2014
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

pulmonary embolism